WHO 2021 data call is now open for both antibacterials and antifungals in the preclinical development pipeline
Opening date: 30 September 2021 at 12:00 Geneva time
Closing date: 30 October 2021 at 23:30 Geneva time
In January 2019 and 2020, the World Health Organization (WHO) released its first performed global reviews of the preclinical antibacterial pipeline, based on publicly available data primarily gathered through a WHO data call.
A 2020 update of the antibacterial preclinical data analyses report was performed and is available on the open source WHO Global Health R&D Observatory, and was published in the WHO Report 2020 antibacterial agents in clinical and preclinical development: an overview and analysis.
WHO 2021 data call for antibacterial, and antifungal agents in preclinical development pipeline
WHO 2021 data call aims to collect data on:
- The 2021 update of WHO analysis and review antibacterial agents in the preclinical development pipeline.
- The first WHO analysis of antifungal agents in the preclinical development pipeline.
The 2021 preclinical data analyses will feed into the WHO Global Health R&D Observatory. The analyses and data will be available for all stakeholders including existing and future funders of R&D.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!